Comorbid Bronchiectasis + Diabetes Tied to Worse Outcomes
A large-scale international study found that comorbid bronchiectasis and diabetes is associated with higher mortality, increased hospitalizations, and more frequent exacerbations.
A large-scale international study found that comorbid bronchiectasis and diabetes is associated with higher mortality, increased hospitalizations, and more frequent exacerbations.
Remote monitoring did not increase the time spent at home after discharge among patients hospitalized with sepsis or lower respiratory tract infection, according to results from a randomized clinical trial of 1,286 adults.
The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.
New research suggests cystic fibrosis transmembrane conductance regulator (CFTR) modulators may provide mental health benefits for pediatric patients and their caregivers early in treatment.
Phase 3 trial results indicate a new antifungal medication olorofim is as effective as current standard treatments for invasive aspergillosis with fewer side effects.
Rextovy, a 4 mg naloxone medication, will be available for purchase without a prescription at retail stores and online.
Healthy lifestyle habits can repress the inflammatory effects of genetic mutations in white blood cells common in seniors.
The collaboration will focus on sleep and circadian medicine, including research into obstructive sleep apnea and wearable health technology.